化学療法: オープンアクセス | 4

社説

EPR-Effect and Nano-medicine Backdoor or Bottleneck?

Gerhard Pütz

この記事をシェアする

解説

First-Line Platinum-Based Chemotherapy Re-challenge in Sensitive Small Cell Lung Cancer (SCLC): A Standard Treatment?

Giovenzio Genestreti, Monica Di Battista, Giovanna Cavallo and Alba Brandes

この記事をシェアする

解説

Resistance in Candida albicans: Exploring the Cell Wall Barrier by Proteomics

Bruno Maras, Giuseppina Mignogna and Letizia Angiolella

この記事をシェアする

解説

Blinatumomab: A Promising New Drug in the Therapeutic Armamentarium for Acute Lymphoblastic Leukemia

Josep-Maria Ribera

この記事をシェアする

解説

The Role of Bevacizumab in the Management of Head and Neck Squamous Cell Carcinoma Patients

Yuh Baba and Yasumasa Kato

この記事をシェアする

解説

Exploring Melissa Officinalis Properties for Glioblastoma Multiforme Treatment

Cerli Rocha Gattass

この記事をシェアする

解説

Neoadjuvant Therapy in Oesophageal Cancer- An International Standard of Care

Nicholas OJ, Frazer R and Gwynne SH

この記事をシェアする

解説

Pulmonary Epithelioid Hemangioendothelioma: Advances in Treatment Options despite a Rare Vascular Tumor

Lilia Bardoscia, Angela Sardaro, Maria Fonte Petruzzelli, Beatrice Detti and Maurizio Portaluri

この記事をシェアする

症例報告

Clinicopathologic Characteristics and Multidisciplinary Treatment of Neuroendocrine Carcinoma of Gallbladderï¼ Report of Three Cases with an Update

Panpan Zhang, Jie Li, Xu Zhu, Jiangyuan Yu, Zhongwu Li, Yongheng Li, Yong Cui, Lin Shen, Wei Deng and Ming Lu

この記事をシェアする

解説

Adjuvant Treatment For Patients With Malignant Peripheral Nerve Sheath Tumours

Matthias Kolberg, Sigbjørn Smeland and Ragnhild A Lothe

この記事をシェアする

解説

Diverse Approval Systems for Autologous Human Cells and Tissue Products

Yano K, Watanabe N and Yamato M

この記事をシェアする

解説

Polymethyoxy Flavonoids: Possible Candidates for Overcoming Drug Resistance

Toshihiko Hirano

この記事をシェアする

症例報告

Langerhans Cell Sarcoma: Treatment with Dose-adjusted EPOCH

Abhisek Swaika, Neha Sood, David M Menke, Asit K Jha and Sikander Ailawadhi

この記事をシェアする

解説

Chemotherapy-Induced Nausea and Vomiting (CINV): the Achilles Heel of Oncologists

Caterina Soldà and Davide Pastorelli

この記事をシェアする

総説

Maintenance Therapy after First Line Chemotherapy Shows Benefit in Advanced Non-Small Cell Lung Cancer

Landre Thierry

この記事をシェアする

化学療法: オープンアクセス
オープンアクセス

音量 4, 問題 3 (2015)

EPR-Effect and Nano-medicine Backdoor or Bottleneck?

First-Line Platinum-Based Chemotherapy Re-challenge in Sensitive Small Cell Lung Cancer (SCLC): A Standard Treatment?

Resistance in Candida albicans: Exploring the Cell Wall Barrier by Proteomics

Blinatumomab: A Promising New Drug in the Therapeutic Armamentarium for Acute Lymphoblastic Leukemia

The Role of Bevacizumab in the Management of Head and Neck Squamous Cell Carcinoma Patients

Exploring Melissa Officinalis Properties for Glioblastoma Multiforme Treatment

Neoadjuvant Therapy in Oesophageal Cancer- An International Standard of Care

Pulmonary Epithelioid Hemangioendothelioma: Advances in Treatment Options despite a Rare Vascular Tumor

Clinicopathologic Characteristics and Multidisciplinary Treatment of Neuroendocrine Carcinoma of Gallbladderï¼ Report of Three Cases with an Update

Adjuvant Treatment For Patients With Malignant Peripheral Nerve Sheath Tumours

Diverse Approval Systems for Autologous Human Cells and Tissue Products

Polymethyoxy Flavonoids: Possible Candidates for Overcoming Drug Resistance

Langerhans Cell Sarcoma: Treatment with Dose-adjusted EPOCH

Chemotherapy-Induced Nausea and Vomiting (CINV): the Achilles Heel of Oncologists

Maintenance Therapy after First Line Chemotherapy Shows Benefit in Advanced Non-Small Cell Lung Cancer

化学療法: オープンアクセスオープンアクセス

音量 4, 問題 3 (2015)

化学療法: オープンアクセス
オープンアクセス